X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (101) 101
humans (98) 98
cardiac & cardiovascular systems (73) 73
male (72) 72
female (68) 68
middle aged (60) 60
cardiovascular (54) 54
heart failure (54) 54
aged (52) 52
article (44) 44
echocardiography (36) 36
heart failure - physiopathology (32) 32
mortality (31) 31
abridged index medicus (26) 26
prognosis (26) 26
hypertension (21) 21
risk factors (21) 21
adult (20) 20
cardiology (20) 20
heart (20) 20
heart failure with preserved ejection fraction (20) 20
risk (20) 20
epidemiology (19) 19
stroke volume - physiology (19) 19
treatment outcome (19) 19
prospective studies (18) 18
analysis (17) 17
internal medicine (17) 17
medical colleges (17) 17
prevalence (17) 17
stroke volume (16) 16
aged, 80 and over (15) 15
diagnosis (15) 15
outcomes (15) 15
risk assessment (15) 15
pulmonary hypertension (14) 14
animals (13) 13
clinical trials (13) 13
comorbidity (13) 13
disease (13) 13
research (13) 13
cardiovascular disease (12) 12
diastolic heart failure (12) 12
follow-up studies (12) 12
management (12) 12
medicine & public health (12) 12
preserved ejection fraction (12) 12
randomized controlled-trial (12) 12
american-society (11) 11
atrial fibrillation (11) 11
cohort studies (11) 11
association (10) 10
diastolic dysfunction (10) 10
diastolic function (10) 10
drug therapy (10) 10
heart attacks (10) 10
heart failure - diagnostic imaging (10) 10
heart-failure (10) 10
peripheral vascular disease (10) 10
exercise (9) 9
heart diseases (9) 9
heart ventricles - physiopathology (9) 9
incidence (9) 9
natriuretic peptides (9) 9
patients (9) 9
retrospective studies (9) 9
severity of illness index (9) 9
spironolactone (9) 9
systolic function (9) 9
cardiac patients (8) 8
dysfunction (8) 8
electrocardiography (8) 8
guidelines (8) 8
health aspects (8) 8
heart failure - diagnosis (8) 8
heart failure - drug therapy (8) 8
heart failure - epidemiology (8) 8
heart ventricles - diagnostic imaging (8) 8
hemodynamics (8) 8
natriuretic peptide, brain - blood (8) 8
predictive value of tests (8) 8
proportional hazards models (8) 8
ultrasonography (8) 8
ventricular dysfunction, left - physiopathology (8) 8
arterial-hypertension (7) 7
atherosclerosis (7) 7
blood pressure (7) 7
cardiovascular system (7) 7
exercise capacity (7) 7
heart failure - complications (7) 7
heart failure - mortality (7) 7
hospitalization (7) 7
hypertrophy (7) 7
population (7) 7
recommendations (7) 7
reproducibility of results (7) 7
research article (7) 7
respiratory system (7) 7
society-of-cardiology (7) 7
studies (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Cardiology, The, ISSN 0002-9149, 2009, Volume 104, Issue 6, pp. 868 - 872
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2016, Volume 151, Issue 5, pp. 1288 - 1299
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 15, pp. 1339 - 1342
  Ivabradine is a highly selective blocker of inward "funny" channels, which are central regulators of spontaneous depolarization in pacemaker cells (19).... 
Cardiovascular | Internal Medicine | heart rate | CARDIAC & CARDIOVASCULAR SYSTEMS | DHF | ivabradine | COMORBIDITIES | EXERCISE CAPACITY | PHOSPHODIESTERASE-5 INHIBITION | RANDOMIZED CONTROLLED-TRIAL | PREVALENCE | randomized controlled trials | diastolic heart failure | TRENDS | Heart failure | Clinical trials | Heart attacks | Drug therapy | Patients | Rodents
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 18, pp. 1976 - 1997
Abstract Pulmonary hypertension (PH) is common and may result from a number of disorders, including left heart disease, lung disease, and chronic... 
Cardiovascular | Internal Medicine | endothelin receptor antagonists | pulmonary arterial hypertension | phosphodiesterase type 5 inhibitors | hemodynamics | echocardiography | prostacyclins | 5 INHIBITOR THERAPY | CARDIAC & CARDIOVASCULAR SYSTEMS | LONG-TERM SURVIVAL | PRESERVED EJECTION FRACTION | RANDOMIZED CONTROLLED-TRIAL | CONTINUOUS INTRAVENOUS EPOPROSTENOL | SOLUBLE GUANYLATE-CYCLASE | CALCIUM-CHANNEL BLOCKERS | ENDOTHELIN RECEPTOR ANTAGONIST | CONTROLLED CLINICAL-TRIAL | DOUBLE-BLIND | Medical History Taking | Tunica Media - pathology | Hypertension, Pulmonary - diagnosis | Vascular Remodeling | Echocardiography | Hypertension, Pulmonary - classification | Atrial Septum - surgery | Humans | Calcium Channel Blockers - therapeutic use | Antihypertensive Agents - therapeutic use | Hypertension, Pulmonary - therapy | Cardiac Catheterization | Exercise Test | Lung Transplantation | Extracorporeal Membrane Oxygenation | Tunica Intima - pathology | Physical Examination | Registries | Phosphodiesterase 5 Inhibitors - therapeutic use | Endothelin Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - etiology | Heart Ventricles - pathology | Pulmonary Artery - pathology | Medical colleges | Respiratory tract diseases | Thromboembolism | Heart diseases | Pulmonary hypertension | Heart | Lupus | Pulmonary arteries | Mortality | Cardiovascular disease | Family medical history | Tropical diseases | Signs | Human immunodeficiency virus--HIV | Medical prognosis | Classification | Mutation | Drug therapy | Cardiology | Veins & arteries
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 9, pp. 1143 - 1146
Corresponding Author 
Cardiovascular | Internal Medicine
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9790, pp. 498 - 506
Summary Background Non-randomised studies of haemopoietic stem-cell transplantation (HSCT) in systemic sclerosis have shown improvements in lung function and... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESOLUTION COMPUTED-TOMOGRAPHY | METAANALYSIS | I-II | AUTOIMMUNE-DISEASES | TERM-FOLLOW-UP | SCLERODERMA LUNG-DISEASE | MARROW TRANSPLANTATION | BLOOD | Cyclophosphamide - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Scleroderma, Systemic - pathology | Male | Tomography, X-Ray Computed | Transplantation, Autologous | Lung - diagnostic imaging | Cyclophosphamide - therapeutic use | Early Termination of Clinical Trials | Scleroderma, Systemic - physiopathology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Immunosuppressive Agents - administration & dosage | Skin - pathology | Severity of Illness Index | Lung - pathology | Drug Administration Schedule | Chicago | Scleroderma, Systemic - surgery | Total Lung Capacity | Treatment Outcome | Lung - physiopathology | Disease Progression | Vital Capacity | Aged | Hematopoietic Stem Cell Transplantation - methods | Infusions, Intravenous | Skin - physiopathology | Therapeutic Equipoise | Transplantation Conditioning | Scleroderma, Systemic - drug therapy | Care and treatment | Cyclophosphamide | Systemic scleroderma | Scleroderma (Disease) | Transplantation | Research | Health aspects | Hematopoietic stem cells | Patient outcomes | Stem cells | Practice | Comparative analysis | Medical research | Blood products | Transplants & implants | Pulmonary arteries | Mortality | Skin | Autoimmune diseases
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 3, pp. 223 - 231
Liver transplantation (LT) candidates today are increasingly older, have greater medical acuity, and have more cardiovascular comorbidities than ever before.... 
Cardiovascular | Internal Medicine | coronary artery disease | liver transplant | end-stage liver disease | DOBUTAMINE STRESS ECHOCARDIOGRAPHY | INTERVAL | CARDIAC & CARDIOVASCULAR SYSTEMS | TRANSESOPHAGEAL ECHOCARDIOGRAPHY | HEART-FAILURE | PREDICTIVE-VALUE | PREVALENCE | PORTOPULMONARY HYPERTENSION | CIRRHOTIC-PATIENTS | PATIENT | CORONARY-ARTERY-DISEASE | Long QT Syndrome - complications | Liver Failure, Acute - complications | Liver Transplantation | Humans | Pulmonary Heart Disease - diagnosis | Cardiovascular System - physiopathology | Long QT Syndrome - diagnosis | Coronary Artery Disease - physiopathology | Foramen Ovale, Patent - diagnosis | Cardiomyopathies - diagnosis | Heart Failure - diagnosis | Pericardial Effusion - complications | Postoperative Complications | Cardiovascular Diseases - diagnosis | Heart Failure - complications | Cardiovascular Diseases - physiopathology | Risk Assessment | Liver Cirrhosis - complications | Pericardial Effusion - diagnosis | Risk Factors | Pulmonary Heart Disease - complications | Animals | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Liver Failure, Acute - surgery | Cardiomyopathies - complications | Liver Cirrhosis - surgery | Foramen Ovale, Patent - complications | Liver Cirrhosis - physiopathology | Hypertension | Medical colleges | Comorbidity | Liver | Risk assessment | Transplantation | Diabetes | Cardiology | Liver cirrhosis | Heart diseases | Heart attack | Heart failure | Heart | Arrhythmia | Cardiovascular disease | Heart attacks | Drug therapy | Mortality
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9872, pp. 1116 - 1124
Summary Background Autologous haemopoietic stem-cell transplantation (HSCT) benefits patients with systemic sclerosis but has been associated with significant... 
Internal Medicine | DIAGNOSIS | RESPONSES | MEDICINE, GENERAL & INTERNAL | MULTICENTER | PULMONARY ARTERIAL-HYPERTENSION | DISEASE | GUIDELINES | TERM-FOLLOW-UP | PULSE CYCLOPHOSPHAMIDE | RIGHT HEART CATHETERIZATION | MARROW TRANSPLANTATION | Follow-Up Studies | Peripheral Blood Stem Cell Transplantation - methods | Compassionate Use Trials | Humans | Middle Aged | Male | Transplantation, Autologous | Hematopoietic Stem Cell Transplantation - mortality | Scleroderma, Diffuse - therapy | Cause of Death | Pulmonary Diffusing Capacity - physiology | Scleroderma, Diffuse - mortality | Young Adult | Scleroderma, Limited - mortality | Pericarditis, Constrictive - mortality | Adult | Female | Retrospective Studies | Heart Failure - mortality | Kaplan-Meier Estimate | Peripheral Blood Stem Cell Transplantation - mortality | Total Lung Capacity | Scleroderma, Limited - therapy | Sepsis - mortality | Scleroderma, Diffuse - physiopathology | Vital Capacity - physiology | Adolescent | Aged | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Scleroderma, Limited - physiopathology | Care and treatment | Systemic scleroderma | Scleroderma (Disease) | Transplantation | Carbon monoxide | Health aspects | Hematopoietic stem cells | Hypertension | Cytomegalovirus | Transplants & implants | Mortality | Colleges & universities | Mental health | Patients | Blood | Quality of life | Ultrasonic imaging | Stem cells | Skin | Scleroderma | Veins & arteries
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 2, pp. 200 - 203
Journal Article
Journal Article